Don’t Forget About the Liver! NASH in Patients With HIV

Download All
Learn about the prevalence, assessment, and current and future treatment landscape for nonalcoholic steatohepatitis in patients with HIV.
Jürgen K. Rockstroh, MD
Giada Sebastiani, MD

Medical Minutes

What puts your patients with HIV at risk for steatohepatitis or NASH? Review the increasing prevalence of fatty liver disease, the spectrum of disease from NAFLD to NASH, and the overlap in the epidemics of NASH and HIV.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 7, 2021 Expired: December 6, 2022

Review the pathogenesis of NASH in patients with HIV, including the role of metabolic comorbidities, long-term ART, and risk factors that contribute to NASH development especially among the aging population.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 6, 2022 Expired: January 5, 2023

Learn best practices for screening strategies and diagnosing NASH in patients with HIV.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 10, 2022 Expired: January 9, 2023

Learn how and why lifestyle modification, weight reduction, and pharmacotherapy may benefit patients with HIV and NASH.

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 10, 2022 Expired: January 9, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Theratechnologies Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings